The ANKRD16 Knockout A-549 Polyclonal Cells product provides a CRISPR/Cas9-mediated polyclonal ANKRD16 gene-disrupted cell population derived from the human A-549 lung adenocarcinoma cell line. This loss-of-function model enables researchers to investigate the role of ANKRD16 in cellular signaling, protein-protein interactions, and cytoskeletal organization without the constraints of clonal selection. The polyclonal format preserves heterogeneous genetic backgrounds, offering a robust system for studying gene function in a biologically relevant context.
A-549 cells are a well-characterized epithelial cell line originating from a human lung carcinoma, commonly employed as a model for type II alveolar epithelial cells. These cells are widely used in cancer research due to their ability to recapitulate key aspects of lung adenocarcinoma biology, including signal transduction pathways governing proliferation, migration, and survival. The A-549 background is particularly suited for exploring oncogenic mechanisms and evaluating potential therapeutic targets in non-small cell lung cancer.
ANKRD16 encodes a protein containing ankyrin repeat domains that function as a scaffold to mediate assembly of multiprotein complexes. ANKRD16 interacts directly with DRG2, actin, and tubulin, linking it to cytoskeletal dynamics and intracellular trafficking. Its expression is regulated by the SP1 transcription factor and the AP-1 complex in response to cellular stress signals. Functionally, ANKRD16 acts upstream of DRG2-dependent signaling cascades and contributes to actin cytoskeleton reorganization, positioning it as a critical node in coordinating signal transduction with structural changes.
In the A-549 lung cancer cell context, disruption of ANKRD16 is anticipated to impair the formation of protein interaction networks that rely on ankyrin repeat scaffolds, potentially leading to altered DRG2 signaling and compromised actin filament dynamics. This knockout model is thus highly relevant for dissecting how ANKRD16-dependent complexes influence phenotypes such as cell proliferation, adhesion, and migration??processes frequently dysregulated in lung adenocarcinoma. Additionally, because ANKRD16 is also implicated in neuronal development, these cells may serve as a surrogate system for investigating conserved cytoskeletal mechanisms shared between cancer and neurological disorders.
Researchers can utilize these ANKRD16 knockout A-549 polyclonal cells in a wide array of experimental workflows. For protein interaction studies, co-immunoprecipitation and western blotting can validate ANKRD16 binding partners and assess downstream DRG2 signaling. Immunofluorescence microscopy enables visualization of actin and tubulin reorganization. Functional assays, including cell proliferation and migration assays, provide quantitative readouts of phenotypic consequences. This product is also suitable for drug target validation and screening campaigns aimed at modulating ankyrin repeat-mediated pathways. For additional support or custom inquiries, please contact Ascent Research.
